InsidersTradesSigma
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (1 ops.)
Insider track record
ExecutiveDisclosed buys
10
Disclosed sells
1
T+90 hit rate
100%
T+90 mean return
+23.5%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Lu Hongbo, Director. Officer active across 3 companies, notably Arrowhead Pharmaceuticals, INC.. Aggregated, 13 reports have been published. Split: 10 buys · 1 sell. Total volume traded: €16.3m. History available since 12 August 2022. The latest transaction was disclosed on 12 May 2026 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Lu Hongbo
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations13 total
13 of 13 declarations
About Lu Hongbo
Lu Hongbo is a director at Arrowhead Pharmaceuticals, INC., Terns Pharmaceuticals, Inc. and Zenas BioPharma, Inc. He has 9 filings in total, and across the 9 sampled filings from 2022-08-16 to 2026-05-14, buys amount to EUR 13325186 and sells to EUR 389135. The modal transaction nature is Acquisition.
